- Corporate Officers - H
- Hunt Ronald
Insider Trading History of Hunt Ronald
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hunt Ronald since 2012.
This trader's CIK number is 1247851.
At the time of last reporting, Hunt Ronald was the Officer of Iterum Therapeutics Plc. (stock ticker symbol ITRM).
Also see all insider trading activities at Iterum Therapeutics Plc.
Note that in the past
HUNT RONALD also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Rallybio Corp (RLYB) by Hunt Ronald
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | RLYB | 307,692 | $3,999,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Relypsa Inc (RLYP) by Hunt Ronald
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | RLYP | 185,978 | $2,045,758 | 0 | $0 | 25,977 | $238,598 |
Yearly summary of insider trading at Iterum Therapeutics Plc (ITRM) by Hunt Ronald
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | ITRM | 0 | $0 | 0 | $0 | 247,934 | $0 |
2023 | ITRM | 0 | $0 | 0 | $0 | 11,513 | $0 |
2022 | ITRM | 0 | $0 | 0 | $0 | 36,798 | $0 |
2020 | ITRM | 0 | $0 | 0 | $0 | 5,703 | $0 |
2018 | ITRM | 662,677 | $8,614,801 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Durata Therapeutics, Inc. (DRTX) by Hunt Ronald
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | DRTX | 784,313 | $7,058,817 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Harpoon Therapeutics, Inc. (HARP) by Hunt Ronald
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | HARP | 1,553,500 | $10,000,000 | 0 | $0 | 0 | $0 |
2021 | HARP | 235,294 | $3,999,998 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Hunt Ronald:
1. Rallybio Corp (RLYB)
2. Relypsa Inc (RLYP)
3. Iterum Therapeutics Plc (ITRM)
4. Durata Therapeutics, Inc. (DRTX)
5. Harpoon Therapeutics, Inc. (HARP)
Table 1. Insider trading of Rallybio Corp (RLYB) by Hunt Ronald
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-08-02 | RLYB | Buy | 307,692 | 13.00 | 3,999,996 |
Table 2. Insider trading of Relypsa Inc (RLYP) by Hunt Ronald
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-11-20 | RLYP | Buy | 185,978 | 11.00 | 2,045,758 |
2013-11-20 | RLYP | Option Ex | 25,977 | 9.19 | 238,598 |
Table 3. Insider trading of Iterum Therapeutics Plc (ITRM) by Hunt Ronald
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-08-06 | ITRM | Option Ex | 247,934 | .00 | 0 |
2023-10-01 | ITRM | Option Ex | 5,479 | .00 | 0 |
2023-07-01 | ITRM | Option Ex | 2,796 | .00 | 0 |
2023-04-01 | ITRM | Option Ex | 2,041 | .00 | 0 |
2023-01-01 | ITRM | Option Ex | 1,197 | .00 | 0 |
2022-06-23 | ITRM | Option Ex | 36,798 | .00 | 0 |
2020-07-01 | ITRM | Option Ex | 5,703 | .00 | 0 |
2018-05-30 | ITRM | Buy | 662,677 | 13.00 | 8,614,801 |
Table 4. Insider trading of Durata Therapeutics, Inc. (DRTX) by Hunt Ronald
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-07-24 | DRTX | Buy | 784,313 | 9.00 | 7,058,817 |
Table 5. Insider trading of Harpoon Therapeutics, Inc. (HARP) by Hunt Ronald
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-10-25 | HARP | Buy | 1,543,500 | .00 | 0 |
2023-03-23 | HARP | Buy | 10,000 | 1,000.00 | 10,000,000 |
2021-01-11 | HARP | Buy | 235,294 | 17.00 | 3,999,998 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hunt Ronald
(Officer of Iterum Therapeutics Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.